These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37986739)

  • 1. A novel mouse model of cerebral adrenoleukodystrophy highlights NLRP3 activity in lesion pathogenesis.
    Hashemi E; Narain Srivastava I; Aguirre A; Tilahan Yoseph E; Kaushal E; Awani A; Kyu Ryu J; Akassoglou K; Talebian S; Chu P; Pisani L; Musolino P; Steinman L; Doyle K; Robinson WH; Sharpe O; Cayrol R; Orchard P; Lund T; Vogel H; Lenail M; Han MH; Bonkowsky JL; Van Haren KP
    bioRxiv; 2023 Nov; ():. PubMed ID: 37986739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abcd1 deficiency accelerates cuprizone-induced oligodendrocyte loss and axonopathy in a demyelinating mouse model of X-linked adrenoleukodystrophy.
    Martinović K; Bauer J; Kunze M; Berger J; Forss-Petter S
    Acta Neuropathol Commun; 2023 Jun; 11(1):98. PubMed ID: 37331971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of adrenoleukodystrophy: From pre-clinical studies to the development of new therapies.
    Ma CY; Li C; Zhou X; Zhang Z; Jiang H; Liu H; Chen HJ; Tse HF; Liao C; Lian Q
    Biomed Pharmacother; 2021 Nov; 143():112214. PubMed ID: 34560537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of adrenoleukodystrophy protein enhances oligodendrocyte disturbance and microglia activation in mice with combined Abcd1/Mag deficiency.
    Dumser M; Bauer J; Lassmann H; Berger J; Forss-Petter S
    Acta Neuropathol; 2007 Dec; 114(6):573-86. PubMed ID: 17828604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IPSC-Derived Astrocytes to Model Neuroinflammatory and Metabolic Responses in X-linked Adrenoleukodystrophy.
    Parasar P; Kaur N; Singh J
    J Biotechnol Biomed; 2023; 6(3):281-293. PubMed ID: 38077449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional genomic analysis unravels a metabolic-inflammatory interplay in adrenoleukodystrophy.
    Schlüter A; Espinosa L; Fourcade S; Galino J; López E; Ilieva E; Morató L; Asheuer M; Cook T; McLaren A; Reid J; Kelly F; Bates S; Aubourg P; Galea E; Pujol A
    Hum Mol Genet; 2012 Mar; 21(5):1062-77. PubMed ID: 22095690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dendrimer-N-acetyl-L-cysteine modulates monophagocytic response in adrenoleukodystrophy.
    Turk BR; Nemeth CL; Marx JS; Tiffany C; Jones R; Theisen B; Kambhampati S; Ramireddy R; Singh S; Rosen M; Kaufman ML; Murray CF; Watkins PA; Kannan S; Kannan R; Fatemi A
    Ann Neurol; 2018 Sep; 84(3):452-462. PubMed ID: 30069915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophy.
    Weinhofer I; Rommer P; Gleiss A; Ponleitner M; Zierfuss B; Waidhofer-Söllner P; Fourcade S; Grabmeier-Pfistershammer K; Reinert MC; Göpfert J; Heine A; Yska HAF; Casasnovas C; Cantarín V; Bergner CG; Mallack E; Forss-Petter S; Aubourg P; Bley A; Engelen M; Eichler F; Lund TC; Pujol A; Köhler W; Kühl JS; Berger J
    EBioMedicine; 2023 Oct; 96():104781. PubMed ID: 37683329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid matrix metalloproteinases are elevated in cerebral adrenoleukodystrophy and correlate with MRI severity and neurologic dysfunction.
    Thibert KA; Raymond GV; Nascene DR; Miller WP; Tolar J; Orchard PJ; Lund TC
    PLoS One; 2012; 7(11):e50430. PubMed ID: 23185624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoprotein nonmetastatic melanoma protein B (GNMPB) as a novel biomarker for cerebral adrenoleukodystrophy.
    Taghizadeh LA; King CJ; Nascene DR; Gupta AO; Orchard PJ; Higgins L; Markowski TW; Nolan EE; Furcich JW; Lund TC
    Sci Rep; 2022 May; 12(1):7985. PubMed ID: 35568699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA Profiling Identifies miR-196a as Differentially Expressed in Childhood Adrenoleukodystrophy and Adult Adrenomyeloneuropathy.
    Shah N; Singh I
    Mol Neurobiol; 2017 Mar; 54(2):1392-1403. PubMed ID: 26843114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of peroxisomal ABC transporters in the mouse adrenal gland: the loss of Abcd2 (ALDR), Not Abcd1 (ALD), causes oxidative damage.
    Lu JF; Barron-Casella E; Deering R; Heinzer AK; Moser AB; deMesy Bentley KL; Wand GS; C McGuinness M; Pei Z; Watkins PA; Pujol A; Smith KD; Powers JM
    Lab Invest; 2007 Mar; 87(3):261-72. PubMed ID: 17260006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Generating human AMN and cALD iPSC-derived astrocytes with potential for modeling X-linked adrenoleukodystrophy phenotypes.
    Kaur N; Singh J
    bioRxiv; 2024 Jun; ():. PubMed ID: 38854155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concurrent axon and myelin destruction differentiates X-linked adrenoleukodystrophy from multiple sclerosis.
    Bergner CG; Genc N; Hametner S; Franz J; van der Meer F; Mitkovski M; Weber MS; Stoltenburg-Didinger G; Kühl JS; Köhler W; Brück W; Gärtner J; Stadelmann C
    Glia; 2021 Oct; 69(10):2362-2377. PubMed ID: 34137074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated cerebral spinal fluid cytokine levels in boys with cerebral adrenoleukodystrophy correlates with MRI severity.
    Lund TC; Stadem PS; Panoskaltsis-Mortari A; Raymond G; Miller WP; Tolar J; Orchard PJ
    PLoS One; 2012; 7(2):e32218. PubMed ID: 22359672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. X-linked adrenoleukodystrophy in a chimpanzee due to an ABCD1 mutation reported in multiple unrelated humans.
    Curiel J; Steinberg SJ; Bright S; Snowden A; Moser AB; Eichler F; Dubbs HA; Hacia JG; Ely JJ; Bezner J; Gean A; Vanderver A
    Mol Genet Metab; 2017 Nov; 122(3):130-133. PubMed ID: 28919002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [X-linked adrenoleukodystrophy].
    Aubourg P
    Ann Endocrinol (Paris); 2007 Dec; 68(6):403-11. PubMed ID: 17532287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abcd2 is a strong modifier of the metabolic impairments in peritoneal macrophages of ABCD1-deficient mice.
    Muneer Z; Wiesinger C; Voigtländer T; Werner HB; Berger J; Forss-Petter S
    PLoS One; 2014; 9(9):e108655. PubMed ID: 25255441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathomechanisms underlying X-adrenoleukodystrophy: a three-hit hypothesis.
    Singh I; Pujol A
    Brain Pathol; 2010 Jul; 20(4):838-44. PubMed ID: 20626745
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.